MedTrace Logo

Lymphedema Study for Arm or Leg Lymphedema

NCT02257970 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2022-10-27

Study results available
· View outcomes & findings →

Summary

This study compares the effectiveness of a study drug versus placebo in the treatment of lymphedema.

Conditions

  • Lymphedema

Interventions

DRUG

Ketoprofen

DRUG

Placebo

Placebo to match ketoprofen.

Sponsors & Collaborators

Principal Investigators

  • Stanley G Rockson, MD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2016-12-31
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02257970 on ClinicalTrials.gov